LPL Financial’s iRadimed IRMD Stock Holding History

LPL Financial’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$281K	Buy	+2,919	New	+$292K	﹤0.01%	5228
2021 Q4	–	Sell	-6,050	Closed	-$203K	–	4400
2021 Q3	$203K	Sell	6,050 -1,250	-17%	-$42.5K	﹤0.01%	3976
2021 Q2	$215K	Buy	+7,300	New	+$201K	﹤0.01%	3856
2019 Q3	–	Sell	-21,585	Closed	-$441K	–	3336
2019 Q2	$441K	Sell	21,585 -3,141	-13%	-$74K	﹤0.01%	2367
2019 Q1	$695K	Buy	+24,726	New	+$647K	﹤0.01%	1934

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's IRMD Position: Q1 2026 in Review

LPL Financial opened a new position in iRadimed (IRMD) in Q1 2026: 2,919 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #5228 among its holdings. This is a return to the name: LPL Financial previously reported a position in IRMD as recently as Q3 2021.

LPL Financial first reported a position in IRMD in Q1 2019 and has held it in 5 quarters since. The position peaked at $695K in Q1 2019. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

LPL Financial held 2,919 shares of iRadimed worth $281K as of Q1 2026.
iRadimed was a new LPL Financial position in Q1 2026.
iRadimed made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5228 holding.
LPL Financial first reported a position in iRadimed in Q1 2019 and has held it in 5 quarters since.
LPL Financial's iRadimed position peaked at $695K in Q1 2019.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.